G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Nucleic Acids Research

• Publication date

  1991-10-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/NAR/19.19.5452-APMID 1681519PMCID PMC328936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

  1986cited by this paper
• Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

  1985cited by this paper

• Genetics of cardiotoxicity induced by anti-HER2 therapies: a systematic review

  2025cites this paper
• Genomic Alterations of Tumors in HER2-Low Breast Cancers

  2024cites this paper
• Association between HER2 (Ile655Val) polymorphism with risk of breast cancer: An extensive meta-analysis

  2024cites this paper
• HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients

  2024cites this paper
• Molecular aspects of BRAF and HER2 in prognosis of periampullary carcinoma.

  2024cites this paper
• Distribution of Her2 Single Nucleotide Polymorphism in Different Geographical location in Sulaimani Province,

  2023cites this paper
• Investigation of HER2 I655V and PHB 3′UTR C > T polymorphisms in azoospermic infertile males

  2023cites this paper
• Genetic polymorphisms and correlation with treatment induced cardiotoxicity and prognosis in breast cancer patients.

  2022cites this paper
• HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.

  2021cites this paper
• Detection of Genetic Polymorphism of HER2 Gene in HER2 Positive Breast Cancer Women in Iraq

  2021cites this paper
• HER2Ile655Val Polymorphism and Risk of Breast Cancer

  2021cites this paper
• Canine mammary cancer

  2020cites this paper
• The Effects of Pertuzumab and Its Combination with Trastuzumab on HER2 Homodimerization and Phosphorylation

  2019cites this paper
• Ile655Val of the HER2 gene and its possible predictive value in patients with hereditary breast and ovarian cancer syndrome

  2019cites this paper
• Nucleic acid amplification-based HER2 molecular detection for breast cancer

  2019cites this paper
• Ile655Val del gen HER2 y su posible valor predictivo en pacientes con síndrome de cáncer de mama y ovario hereditario

  2019cites this paper
• Frequency of I655V SNP of HER-2/neu in colorectal cancer: a study from India

  2019cites this paper
• HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility

  2018cites this paper
• Her2Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies

  2018cites this paper
• Association between tobacco and alcohol consumption, HER2 polymorphisms and response to trastuzumab in HER2-positive breast cancer patients

  2017cites this paper
• Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2‐Positive Breast Cancer Patients

  2017cites this paper
• The human epidermal growth factor receptor 2 (HER2) in the breast cancer : from measurement to targeted treatment

  2017cites this paper
• Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer.

  2016cites this paper
• Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.

  2016cites this paper
• Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study

  2016cites this paper
• Association of HER2 codon 655 polymorphism with ovarian cancer

  2016influential citation
• Development of Sybr Green I-Based Melting Curve Method for HER2I655V Polymorphism Detection in Breast Cancer

  2016cites this paper
• Role of HER-2 Ile655Val Polymorphism as Universal Cancer Susceptibility Marker among Different Cancers.

  2016cites this paper
• HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.

  2015cites this paper
• BRCA1, BRCA2, HER2 and RAD51 gene polymorphisms in breast cancer patients of Bangladesh

  2015cites this paper
• A Study of Her-2/Neu SNP in Breast Cancer Patients

  2015cites this paper
• Platelet Derived Growth Factor-B and Human Epidermal Growth Factor Receptor-2 Polymorphisms in Gall Bladder Cancer.

  2015cites this paper
• Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients

  2015cites this paper
• HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.

  2015cites this paper
• Pharmacogenetics and breast cancer management: current status and perspectives

  2015cites this paper
• Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.

  2014cites this paper
• Association between the HER 2 Ile 655 Val polymorphism and response to trastuzumab in women with operable primary breast cancer

  2014cites this paper
• Allellic HER-2 codon 655 polymorphism and the influence of plasma HER-2 levels in breast cancer Egyptian female patients

  2014cites this paper
• Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.

  2014cites this paper
• HER2 CODON 655 POLYMORPHISM IN HER2 NEGATIVE LUNG CANCER PATIENTS - NEW PROPOSAL FOR ONE OLD DIAGNOSIS

  2014cites this paper
• Pharmacogénétique et thérapies ciblées

  2014cites this paper
• Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d'un nou subtipus de càncer de mama (Basal/ErbB2+)

  2013cites this paper
• Pharmacogenetic study of Fc gamma receptor and HER2 genes in breast cancer

  2013cites this paper
• Polymorphism and overexpression of HER2/neu among ovarian carcinoma women from Tiruchirapalli, Tamil Nadu, India

  2013cites this paper
• Polymorphic Ala-allele carriers at residue 1170 of HER2 associated with Parkinson's disease.

  2013cites this paper
• Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab.

  2013cites this paper
• Polymorphisms of ERBB2 and breast cancer risk: A meta‐analysis of 26 studies involving 35,088 subjects

  2013cites this paper
• ErbB2, EphrinB1, Src Kinase and PTPN13 Signaling Complex Regulates MAP Kinase Signaling in Human Cancers

  2012cites this paper
• Mechanistic Investigation of Tolfenamic Acid, Betulinic Acid, and Aspirin in Anti-Cancer Therapy

  2012cites this paper
• Breast cancer and HER3; the possibilities of imaging with VHH probes

  2011cites this paper
• Ile/Ile homozygosity at codon 655 of HER2 in schwannoma.

  2011cites this paper
• ERBB 2 ( erythroblastic leukemia viral oncogene homolog 2 , neuro / glioblastoma derived oncogene homolog ( avian ) )

  2011cites this paper
• ERBB2 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian))

  2011cites this paper
• Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects

  2010cites this paper
• HER2 codon 655 polymorphism is associated with advanced uterine cervical carcinoma.

  2010cites this paper
• Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments

  2010cites this paper
• HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies

  2010cites this paper
• HER2 Polymorphisms and Breast Cancer in Tunisian Women

  2010influential citation
• P53 Codon 72 and HER2 Codon 655 Polymorphisms in Turkish Breast Cancer Patients

  2010cites this paper
• The HER3 Receptor: Role as an Intervention Target in Ovarian Cancer

  2010cites this paper
• Significance of Serum Tumor Necrosis Factor-Alpha and its Combination with Her-2 Codon 655 Polymorphism in the Diagnosis and Prognosis of Breast Cancer

  2010cites this paper
• Transmembrane helix-helix interactions involved in ErbB receptor signaling

  2010cites this paper
• The Val allele of HER-2 codon 655 predicts the progression of oral squamous cell carcinoma.

  2009cites this paper
• Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.

  2009cites this paper
• Comparative binding analysis of monoclonal antibodies against native and mutant type in ErbB2 receptor: a theoretical modeling approach.

  2009cites this paper
• HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis

  2009cites this paper
• Effect of deleterious nsSNP on the HER2 receptor based on stability and binding affinity with herceptin: a computational approach.

  2008cites this paper
• A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan.

  2008cites this paper
• Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.

  2008cites this paper
• The Influence of HER2 Genotypes as Molecular Markers on Breast Cancer Outcome

  2008cites this paper
• HER‐2/neu Ile655Val Polymorphism and the Risk of Breast Cancer

  2008cites this paper
• Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.

  2008cites this paper
• Focus on ERBB2.

  2008cites this paper
• The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.

  2008cites this paper
• ERBB2 genetic polymorphism and breast cancer risk in Chinese women: a population-based case-control study

  2008influential citation
• Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma

  2008cites this paper
• HER-2, polymorphismes génétiques et cancer du sein

  2008cites this paper
• Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer

  2008cites this paper
• Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.

  2007cites this paper
• Genetic Predisposition to Breast and Ovarian Cancer in Eastern Finnish

  2007cites this paper
• Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Gene Polymorphisms in Endometrial Cancer in a Japanese Population

  2007cites this paper
• HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.

  2006cites this paper
• Evaluation of the HER2/neu‐derived peptide GP2 for use in a peptide‐based breast cancer vaccine trial

  2006influential citation
• Dendritic cell based cancer vaccines using adenovirally mediated expression of the HER-2/neu gene and apoptotic tumor cells expressing heat shock protein 70

  2006cites this paper
• Investigation of HER-2 codon 655 single nucleotide polymorphism frequency and c-ErbB-2 protein expression alterations in gastric cancer patients.

  2006cites this paper
• THRAI and DI7S 183 Flank an Interval of <4 cM for the Breast-Ovarian Cancer Gene (BRCA I) on Chromosome 1 7q2

  2006cites this paper
• Pharmacogénétique des récepteurs HER

  2005cites this paper
• A Haplotype Analysis of HER-2 Gene Polymorphisms: Association with Breast Cancer Risk, HER-2 Protein Expression in the Tumor, and Disease Recurrence in Korea

  2005cites this paper
• Involvement of adenomatous polyposis coli in colorectal tumorigenesis.

  2005cites this paper
• Predicting drug response and toxicity based on gene polymorphisms.

  2005cites this paper
• HER‐2 gene polymorphism at codon 655 in familial prostate cancer in a Japanese population

  2005cites this paper
• Her2 genotype and breast cancer progression in Korean women.

  2005cites this paper
• A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer

  2005cites this paper
• Her2V655 genotype and breast cancer progression in Korean women

  2005cites this paper
• HER-2 codon 655 polymorphism in cervical carcinogenesis

  2005cites this paper
• The influence of HER2 genotypes as molecular markers in ovarian cancer outcome.

  2005cites this paper
• Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.

  2004cites this paper
• HER2 polymorphism and breast cancer risk in Portugal

  2004cites this paper
• Molecular and functional characteristics of erbB2 in normal and cancer breast cells.

  2004cites this paper
• Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.

  2004cites this paper